Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Theratechnologies < Previous 1 2 Next > Theratechnologies Announces Pricing of US$25 Million Public Offering of Common Shares and Concurrent Private Placement October 26, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Announces Proposed Public Offering of Common Shares and Concurrent Private Placement October 25, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Announces Operational Update October 24, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies’ Ibalizumab Demonstrates Cost-Effectiveness as an Addition to Routine Clinical Care in Heavily Treatment-Experienced People with HIV October 19, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Announces Finalization of Amendments to Some of the Terms and Conditions of its Credit Agreement with Marathon October 16, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Presents Data at ID Week Showing Tesamorelin Reduces Visceral Adipose Tissue (VAT) and Liver Fat in People with HIV on Integrase Inhibitors (INSTIs) October 13, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Announces Results from Trogarzo® (Ibalizumab-uiyk) Intramuscular Administration Study October 13, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Announces Dosing of First Patient in Updated Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer October 12, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Receives January 2024 PDUFA Goal Date for Tesamorelin F8 Formulation sBLA October 04, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Reports Financial Results for the Third Quarter and Nine Months of Fiscal 2023 and Provides Business Updates September 26, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Announces Agreement in Principle with Marathon to Amend Some of the Terms and Conditions of its Loan Facility September 25, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Submits Tesamorelin F8 Formulation sBLA for FDA Review September 25, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference 2023 September 20, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies to Announce Third Quarter 2023 Financial Results and Provide Business Update September 18, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies to Present at the H.C. Wainwright 25th Annual Global Investment Conference September 07, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Announces Certain Preliminary Q3 2023 Financial Highlights September 05, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Announces All U.S. Oncology Clinical Sites Now Enrolling for Phase 1 Trial of Sudocetaxel Zendusortide August 30, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Completes 1-for-4 Reverse Stock Split July 31, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Announces Amendments to its Term Loan Facility With Affiliates of Marathon Asset Management July 28, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Announces the Resignation of One of Its Directors, Mr. Gary Littlejohn July 21, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Announces 1-for-4 Reverse Stock Split July 20, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Reports Second Quarter 2023 Financial Results and Business Updates July 12, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies to Announce Second Quarter 2023 Financial Results and Provide Business Update June 29, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Draws Down on US$20 Million Second Tranche Under its Term Loan Facility With Affiliates of Marathon Asset Management June 22, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies June 13 Oncology Investigator Call to Update Investors & Analysts on Phase 1 Sudocetaxel Zendusortide Trial June 12, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide June 02, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies to Present Preliminary Safety and Efficacy Data from Phase 1 Trial of Sudocetaxel Zendusortide in Heavily Pretreated Cancer Patients at ASCO 2023 May 25, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Reports on its Annual Meeting of Shareholders May 09, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies’ Trogarzo® (Ibalizumab-uiyk) Shortens Time to HIV Undetectability and Extends Durability of Undetectability and Viral Suppression in a Matched Treatment Comparison May 04, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH Theratechnologies Data Presentations at AACR 2023 Showcase Potential of Sudocetaxel Zendusortide as a Single Agent and in Combination with other Anticancer Therapies April 18, 2023 From Theratechnologies Via GlobeNewswire Tickers THTX TSX:TH < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.